JP2006517932A5 - - Google Patents

Download PDF

Info

Publication number
JP2006517932A5
JP2006517932A5 JP2006501608A JP2006501608A JP2006517932A5 JP 2006517932 A5 JP2006517932 A5 JP 2006517932A5 JP 2006501608 A JP2006501608 A JP 2006501608A JP 2006501608 A JP2006501608 A JP 2006501608A JP 2006517932 A5 JP2006517932 A5 JP 2006517932A5
Authority
JP
Japan
Prior art keywords
group
alkyl
branched
linear
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006501608A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006517932A (ja
JP4724651B2 (ja
Filing date
Publication date
Priority claimed from IT000287A external-priority patent/ITMI20030287A1/it
Application filed filed Critical
Publication of JP2006517932A publication Critical patent/JP2006517932A/ja
Publication of JP2006517932A5 publication Critical patent/JP2006517932A5/ja
Application granted granted Critical
Publication of JP4724651B2 publication Critical patent/JP4724651B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006501608A 2003-02-18 2004-01-26 鎮痛作用を有するインダゾールアミド Expired - Fee Related JP4724651B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000287A ITMI20030287A1 (it) 2003-02-18 2003-02-18 Indazolammidi dotate di attivita' analgesica metodo, per
ITMI2003A000287 2003-02-18
PCT/EP2004/000647 WO2004074275A1 (en) 2003-02-18 2004-01-26 Indazolamides with analgesic activity

Publications (3)

Publication Number Publication Date
JP2006517932A JP2006517932A (ja) 2006-08-03
JP2006517932A5 true JP2006517932A5 (enExample) 2007-05-31
JP4724651B2 JP4724651B2 (ja) 2011-07-13

Family

ID=32894157

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006501608A Expired - Fee Related JP4724651B2 (ja) 2003-02-18 2004-01-26 鎮痛作用を有するインダゾールアミド

Country Status (22)

Country Link
US (2) US7632849B2 (enExample)
EP (1) EP1594859B1 (enExample)
JP (1) JP4724651B2 (enExample)
KR (1) KR101108222B1 (enExample)
CN (2) CN100347168C (enExample)
AR (1) AR043186A1 (enExample)
AT (1) ATE471934T1 (enExample)
AU (1) AU2004213104B2 (enExample)
CA (1) CA2511984C (enExample)
DE (1) DE602004027792D1 (enExample)
DK (1) DK1594859T3 (enExample)
EA (1) EA009077B1 (enExample)
ES (1) ES2345983T3 (enExample)
GE (1) GEP20074075B (enExample)
IL (1) IL169285A (enExample)
IT (1) ITMI20030287A1 (enExample)
MX (1) MXPA05008730A (enExample)
PL (1) PL215870B1 (enExample)
PT (1) PT1594859E (enExample)
SI (1) SI1594859T1 (enExample)
UA (1) UA79537C2 (enExample)
WO (1) WO2004074275A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20031468A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco ativo nel dolore neuropatico
EA010891B9 (ru) * 2004-06-15 2012-08-30 Пфайзер Инк. Производные бензимидазолонкарбоновой кислоты
PL2105164T3 (pl) * 2008-03-25 2011-05-31 Affectis Pharmaceuticals Ag Nowi antagoniści P2X7R i ich zastosowanie
US8815892B2 (en) 2008-03-25 2014-08-26 Affectis Pharmaceuticals Ag P2X7R antagonists and their use
SI2243772T1 (sl) * 2009-04-14 2012-05-31 Affectis Pharmaceuticals Ag Novi antagonisti p x r in njihova uporaba
US9611249B2 (en) 2012-02-12 2017-04-04 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
SG10201701171TA (en) * 2012-02-21 2017-04-27 Acraf Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
CA2905242C (en) 2013-03-15 2016-11-29 Pfizer Inc. Indole compounds that activate ampk
UA128089C2 (uk) 2018-05-07 2024-04-03 Ацьєнде Кіміке Ріуніте Анджеліні Франческо - А.Чі.Р.А.Ф. С.П.А. 1h-індазол-3-карбоксамідні сполуки як інгібітори кінази-3 бета глікогенсинтази
CN109336890B (zh) * 2018-11-17 2020-03-20 重庆文理学院 一种吲唑类衍生物的合成方法及抗肿瘤应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3705175A (en) * 1969-04-01 1972-12-05 Egyt Gyogyszervegyeszeti Gyar Indazole-3-carboxylic amides
IL117438A (en) 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
US5654320A (en) * 1995-03-16 1997-08-05 Eli Lilly And Company Indazolecarboxamides
WO1996038420A1 (en) * 1995-05-31 1996-12-05 Nisshin Flour Milling Co., Ltd. Indazole derivatives having monocyclic amino group
WO1997017208A1 (fr) * 1995-11-08 1997-05-15 Toray Industries, Inc. Plaque planographique originale, sans eau, pour dessin direct
NZ334064A (en) 1996-08-16 2000-08-25 Smithkline Beecham Plc Process for the preparation of N-[(1-nbutyl-4-piperidyl)methyl] -3,4-dihydro-2H-[1,3]oxazino[3,2-a] indole-10-carboxamide and salts and intermediates in the process
IT1291569B1 (it) 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
US6339087B1 (en) * 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
US6407103B2 (en) * 1998-04-21 2002-06-18 Bristol-Myers Squibb Pharma Company Indeno [1,2-c] pyrazol-4-ones and their uses
EP1071668B1 (en) * 1998-04-21 2009-06-03 Bristol-Myers Squibb Pharma Company 5-aminoindeno[1,2-c]pyrazol-4-ones as anti-cancer and anti-proliferative agents

Similar Documents

Publication Publication Date Title
RU2397168C2 (ru) Производные тиофена в качестве ингибиторов снк 1
JP2008505157A5 (enExample)
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
RU2011137457A (ru) Пестицыдные композиции
MY142807A (en) Benzimidazole derivative and use thereof.
JP2013507423A5 (enExample)
JP2012512863A5 (enExample)
HRP20140950T1 (hr) Novi spojevi i pripravci, te postupci njihove primjene
BR0307409A (pt) Compostos de hidrazida de ácido 2-furanocarboxìlico, composições farmacêuticas contendo os mesmos e uso dos mesmos para preparação de um agente preventivo ou terapêutico
PE20040164A1 (es) Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas
MX2010008101A (es) Derivados de indol 2-carboxamidas y de azaindol 2-carboxamidas sustituidos con un silanilo, su preparacion y su aplicacion en terapeutica.
JP2005053931A5 (enExample)
RU2010133903A (ru) Способ и промежуточные соединения для получения производных 5-бифенил-4-ил-2-метилпентановой кислоты
MA29649B1 (fr) Nouveaux derives de 2,4- dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
MY145031A (en) N-(aminoheteroaryl)-1h-indole-2carboxamide derivatives, and preparation and therapeutic application thereof
NO20076006L (no) Acetylenderivater
JP2006517932A5 (enExample)
WO2008107502A8 (es) Composicion para el tratamiento de enfermedades infecciosas
NO20064297L (no) Aminoalkoholforbindelse
CA2744756A1 (en) Monocarbams and their use as antibacterial agent
RU2009102270A (ru) Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы
JP2019535723A5 (enExample)
JP2014505017A5 (enExample)
CA2657773A1 (en) Dental compositions comprising a phosphorylated pullulan, a cationic bactericidal agent and a solvent
RU2403253C2 (ru) Пуриновые производные для применения в качестве агонистов аденозинового рецептора а-2а